missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18681720

Granzyme B Antibody (351927), DyLight 680, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals FAB2906Y

Product Code. 18681720

  • € 663.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Granzyme B Monoclonal antibody specifically detects Granzyme B in Human samples. It is validated for Western Blot, Simple Western, Immunohistochemistry, Flow Cytometry (Intracellular Staining), Immunocytochemistry, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Granzyme B
Monoclonal
DyLight 680
50mM Sodium Borate
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Western Blot, Simple Western, Immunohistochemistry, Flow Cytometry (Intracellular Staining), Immunocytochemistry, CyTOF
351927
Western Blot, Simple Western, Immunohistochemistry, Intracellular Staining by Flow Cytometry, Immunocytochemistry, CyTOF-ready
C11, CCPI, CGL1, CGL-1, CSPB, CSP-B, CTLA1, CTSGL1, granzyme B, GranzymeB, GZMB, HLP, SECT
Mouse myeloma cell line NS0-derived recombinant human Granzyme B, Gly19-Tyr247, Accession # P10144
0.1 mL
Apoptosis
3002
Store at 4°C in the dark.
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.